1) From the recent annual meeting of the American Society of Tropical Medicine & Hygiene (abstract 6949) we learn that the R21/Matrix-M malaria vaccine maintained it’s efficacy over 4 seasons. …Importantly, maintained high efficacy over four malaria seasons with only four doses is demonstrated, with no concerns to date of rebound in those who have
The post Two Updates on the Value of Vaccines appeared first on Marginal REVOLUTION.
1) From the recent annual meeting of the American Society of Tropical Medicine & Hygiene (abstract 6949) we learn that the R21/Matrix-M malaria vaccine maintained it’s efficacy over 4 seasons.
…Importantly, maintained high efficacy over four malaria seasons with only four doses is demonstrated, with no concerns to date of rebound
in those who have not received repeated booster doses of the malaria vaccine. These data show that the R21/MM vaccine could significantly
reducing malaria cases and deaths in children living in malaria endemic areas by inducing well maintained protective immunity.
This is excellent news and further supports my call for rapid, emergency distribution of malaria vaccines.
2) Glennerster, Kelly, McMahon, and Snyder estimate the value of a universal coronavirus vaccine. The COVID vaccines have been very valuable (see our Science paper) but each new variant of concern causes a spike in death rates. As new variants emerge, we modify the vaccines but that takes time and happens only after the death rate spikes. In addition, no one is thrilled with boosters. A universal coronavirus vaccine, and there are dozens in the works, could preclude the need to adjust vaccines on the fly and avoid or greatly ameliorate the death spikes. Based on reduced US mortality alone, Glennerster et al. estimate that a universal vaccine would be very valuable–so much so that an Advance Market Commitment on the order of $6-$10 billion would easily pass a cost-benefit test even if it had just say a 40% chance of accelerating a universal vaccine.
As I said repeatedly during COVID, billions<<Trillions.
The post Two Updates on the Value of Vaccines appeared first on Marginal REVOLUTION.
Current Affairs, Economics, Law, Medicine
Leave a Reply